Search Results - Владимир Стругов

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial

    First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, ph... by Carol Moreno, Richard Greil, Fatih Demırkan, Alessandra Tedeschi, Bertrand Anz, Loree Larratt, Martin Šimkovič, Jan Novák, Владимир Стругов, Devinder Gill, John G. Gribben, Kevin Kwei, Sandra Dai, Emily Hsu, James P. Dean, Ian W. Flinn

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    <i>BTK</i> and <i>PLCG2</i> remain unmutated in one-third of patients with CLL relapsing on ibrutinib

    <i>BTK</i> and <i>PLCG2</i> remain unmutated in one-third of patients with CLL relapsing on ibrutinib by Silvia Bonfiglio, Lesley‐Ann Sutton, Viktor Ljungström, Antonella Capasso, Tatjana Pandzic, Simone Weström, Hassan Foroughi Asl, Aron Skaftason, Anna Gellerbring, Anna Lyander, Francesca Gandini, Gianluca Gaïdano, Livio Trentin, Lisa Bonello, Gianluigi Reda, Csaba Bödör, Niki Stavroyianni, Constantine S. Tam, Roberto Marasca, Francesco Forconi, Panayiotis Panayiotidis, Ingo Ringshausen, Ozren Jakšić, Anna Maria Frustaci, Sunil Iyengar, Marta Coscia, Stephen P. Mulligan, Loïc Ysebaert, Владимир Стругов, Carolina Pavlovsky, Renata Walewska, Anders Österborg, Diego Cortese, Pamela Ranghetti, Panagiotis Baliakas, Κώστας Σταματόπουλος, Lydia Scarfò, Richard W. Rosenquist, Paolo Ghia

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

    COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus by Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, Giulia Quaresmini, Marina Motta, Candida Vitale, José A. García‐Marco, José‐Ángel Hernández‐Rivas, Fatima Mirás, Mónica Baile, Juan Marquet, Carsten Utoft Niemann, Gianluigi Reda, Talha Munir, Eva Gimeno, Monia Marchetti, Francesca Maria Quaglia, Marzia Varettoni, Julio Delgado, Sunil Iyengar, Ann Janssens, Roberto Marasca, Angela Ferrari, Carolina Cuéllar‐García, Gilad Itchaki, Martin Špaček, Lorenzo De Paoli, Luca Laurenti, Mark‐David Levin, Enrico Lista, Francesca Romana Mauro, Martin Šimkovič, Ellen van der Spek, Elisabeth Vandenberghe, Livio Trentin, Ewa Wąsik‐Szczepanek, Rosa Ruchlemer, Dominique Bron, Maria Rosaria De Paolis, Giovanni Del Poeta, Lucia Farina, Myriam Foglietta, Massimo Gentile, Yair Herishanu, Tobias Herold, Ozren Jakšić, Arnon P. Kater, Sabina Kersting, Lara Malerba, Lorella Orsucci, Viola Maria Popov, Paolo Sportoletti, Mohamed A. Yassin, Barbara Pocali, Gábor Barna, Annalisa Chiarenza, Gimena dos Santos, Eugene Nikitin, Martin Andres, Maria Dimou, Michael Doubek, Alicia Enrico, Yervand Hakobyan, Olga Kalashnikova, Macarena Ortiz Pareja, Maria Papaioannou, Davide Rossi, Nimish Shah, Amit Shrestha, Oana Stanca, Niki Stavroyianni, Владимир Стругов, Constantine S. Tam, Mihnea Zdrenghea, Marta Coscia, Κώστας Σταματόπουλος, Giuseppe Rossi, Alessandro Rambaldi, E Montserrat, Robin Foà, Antonio Cuneo, Paolo Ghia

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: